← Alle mensen

AM

Ana M Arance

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Nivolumab for Resected Stage III or IV Melanoma at 9 Years.
The New England journal of medicine · 22 januari 2026
Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024-11
Adjuvant nivolumab versus ipilimumab bij melanoom: CheckMate 238 vierjaars herbeoordeling
European journal of cancer (Oxford, England : 1990) · 2022-09
Adjuvant nivolumab versus ipilimumab bij melanoom: CheckMate 238 vierjaars
The Lancet. Oncology · 2020-11
Adjuvant nivolumab versus ipilimumab bij gereseceerd stadium III/IV melanoom: CheckMate 238
The New England journal of medicine · 9 november 2017